Investment Q&A

• Intuitive Surgical Inc. (ISRG $586.24)
  • $586.24 P/E (TTM): 77.29X Cap: $207.81B
  • View ISRG Profile
  • View Questions on ISRG
• Edwards Lifesciences Corporation (EW $85.13)
  • $85.13 P/E (TTM): 36.46X Cap: $49.40B
  • View EW Profile
  • View Questions on EW
• Stryker Corporation (SYK $367.54)
  • $367.54 P/E (TTM): 48.25X Cap: $140.55B
  • View SYK Profile
  • View Questions on SYK
• Mettler-Toledo International Inc. (MTD $1,485.12)
  • $1,485.12 P/E (TTM): 36.58X Cap: $30.33B
  • View MTD Profile
  • View Questions on MTD

Q: Good afternoon,

Looking for your assessment after what seems to be another disappointing quarter?
I own the stock, are there better places for healthcare exposure?

Thank you.

Upvote 0

Read Answer Asked by Brad on May 27, 2022

• Harvest Healthcare Leaders Income ETF (HHL $7.89)
  • $7.89 P/E (TTM): 23.05X Cap: $1.63B
  • View HHL Profile
  • View Questions on HHL

Q: HI GUYS I was wondering if this company would be ok to buy because the price seems fair and it pays good divivdend, I cant find any news on it or do you have anything else in that price range that may be worth looking at. I am looking to buy it in my tfsa thanks so much Larry

Upvote 0

Read Answer Asked by Larry on May 27, 2022

• ALPS Medical Breakthroughs ETF (SBIO $51.37)
  • $51.37 P/E (TTM): 17.05X Cap: $128M
  • View SBIO Profile
  • View Questions on SBIO

Q: Hi Team
I started a position in this ETF today. What do you think for a long term hold. Obviously the Sector will be huge in the future,
Thanks Gord

Upvote 0

Read Answer Asked by Gordon on May 26, 2022

• Intuitive Surgical Inc. (ISRG $586.24)
  • $586.24 P/E (TTM): 77.29X Cap: $207.81B
  • View ISRG Profile
  • View Questions on ISRG

Q: Over the last month ISRG is down precipitously vs the industry (stryker, IHI). Is there a particular reason this stock is down so much? Thanks
Mike

Upvote 0

Read Answer Asked by Michael on May 25, 2022

• WELL Health Technologies Corp. (WELL $4.23)
  • $4.23 Cap: $1.07B
  • View WELL Profile
  • View Questions on WELL
  • View Reports on WELL

Q: I own 3000 shares of WELL at $7.56 and have been thinking of averaging down. Do you believe WELL at current $3.69, is a buy for this purpose?

Upvote 0

Read Answer Asked by Bob on May 24, 2022

• Medical Properties Trust Inc. (MPW $5.42)
  • $5.42 Cap: $3.26B
  • View MPW Profile
  • View Questions on MPW
• Community Healthcare Trust Incorporated (CHCT $16.90)
  • $16.90 Cap: $481M
  • View CHCT Profile
  • View Questions on CHCT
• LTC Properties Inc. (LTC $35.48)
  • $35.48 P/E (TTM): 50.15X Cap: $1.68B
  • View LTC Profile
  • View Questions on LTC

Q: Discovered this Long Term Care Properties company in the US with monthly dividends of 6%. Do you think this is a stock worth holding to have exposure to US health care? And is dividend sustainable as it seems to have a large payout from my novice analysis. Appreciate your expert analysis very much.

Upvote 0

Read Answer Asked by Dr Lorraine on May 24, 2022

• AbCellera Biologics Inc. (ABCL $4.37)
  • $4.37 Cap: $1.28B
  • View ABCL Profile
  • View Questions on ABCL

Q: Is ABCL a buy, hold or sell at this point ? Thanks for this great service.

Upvote 0

Read Answer Asked by Christopher on May 24, 2022

• Defence Therapeutics Inc. Class A (DTC $0.68)
  • $0.68 Cap: $38M
  • View DTC Profile
  • View Questions on DTC

Q: DTC ... YOUR opinion on buying this based on recent publication results

Upvote 0

Read Answer Asked by Bob on May 24, 2022

• Intuitive Surgical Inc. (ISRG $586.24)
  • $586.24 P/E (TTM): 77.29X Cap: $207.81B
  • View ISRG Profile
  • View Questions on ISRG
• Medtronic plc. (MDT $97.53)
  • $97.53 P/E (TTM): 26.67X Cap: $125.03B
  • View MDT Profile
  • View Questions on MDT
• Stryker Corporation (SYK $367.54)
  • $367.54 P/E (TTM): 48.25X Cap: $140.55B
  • View SYK Profile
  • View Questions on SYK
• Penumbra Inc. (PEN $322.44)
  • $322.44 P/E (TTM): 75.13X Cap: $12.38B
  • View PEN Profile
  • View Questions on PEN
• Lantheus Holdings Inc. (LNTH $67.56)
  • $67.56 P/E (TTM): 28.63X Cap: $4.48B
  • View LNTH Profile
  • View Questions on LNTH

Q: Do you have three or four names in the medical equipment sector that you expect will do well this coming year.?

Upvote 0

Read Answer Asked by Mike on May 24, 2022

• Quipt Home Medical Corp. (QIPT $4.92)
  • $4.92 Cap: $216M
  • View QIPT Profile
  • View Questions on QIPT

Q: Morning
Your opinion on earnings please, I have a small position and want to slowly add to healthcare for the next leg up whenever that might be.

Upvote 0

Read Answer Asked by Dave on May 20, 2022

• MCI Onehealth Technologies Inc. Class A Subordinate Voting Shares (DRDR)
  • Cap: $66M
  • View DRDR Profile
  • View Questions on DRDR

Q: DRDR just reported their last quarter. While sales are going up, they never seem to make any money, even EBITDA negative. Your thoughts please. Thanks

Upvote 0

Read Answer Asked by george on May 20, 2022

• WELL Health Technologies Corp. (WELL $4.23)
  • $4.23 Cap: $1.07B
  • View WELL Profile
  • View Questions on WELL
  • View Reports on WELL

Q: Any comments or opinions about today's announced bought deal of new shares of Well? The offering price seems low, it looks as though they waited for a dip to make the offering. Are we existing shareholders getting a raw deal?

Upvote 0

Read Answer Asked by John on May 19, 2022

• Sernova Biotherapeutics Inc. (SVA $0.15)
  • $0.15 Cap: $48M
  • View SVA Profile
  • View Questions on SVA
• Evotec SE (EVO $3.66)
  • $3.66 Cap: $324M
  • View EVO Profile
  • View Questions on EVO

Q: Under the "lottery ticket" portion of my portfolio I own SVA, they announced a deal with EVO. RBC has no information on EVO, what can you tell me about EVO, thoughts on the deal?

Upvote 0

Read Answer Asked by Charles on May 19, 2022

• State Street Health Care Select Sector SPDR ETF (XLV $157.31)
  • $157.31 P/E (TTM): 24.15X Cap: $40.34B
  • View XLV Profile
  • View Questions on XLV
• iShares Biotechnology ETF (IBB $172.39)
  • $172.39 P/E (TTM): 21.3X Cap: $8.43B
  • View IBB Profile
  • View Questions on IBB
• Harvest Healthcare Leaders Income ETF (HHL.U $8.66)
  • $8.66 P/E (TTM): 23.05X Cap: $114M
  • View HHL.U Profile
  • View Questions on HHL.U

Q: Good Morning
Can you please give your opinion on Harvest Healthcare Leaders ETF or is there another healthcare purchase you would suggest.
Also would this be a good time to purchase.
Thank you
Heather

Upvote 0

Read Answer Asked by Heather on May 18, 2022

• Mind Medicine Inc (Sub Voting) (MMEDF)
  • P/E (TTM): -36.9X Cap: $1.52B
  • View MMEDF Profile
  • View Questions on MMEDF

Q: there's some fringe companies doing experiments with magic mushrooms to treat anxiety, depression and a number of other ailments. If this takes off do you think this could have lots of upside , or will this be attacked by large drug makers whose patented drugs could loose market share ? Thanks alot.

Upvote 1

Read Answer Asked by jim on May 17, 2022

• Knight Therapeutics Inc. (GUD $5.98)
  • $5.98 Cap: $596M
  • View GUD Profile
  • View Questions on GUD
  • View Reports on GUD
• WELL Health Technologies Corp. (WELL $4.23)
  • $4.23 Cap: $1.07B
  • View WELL Profile
  • View Questions on WELL
  • View Reports on WELL

Q: Please comment on earnings

Upvote 0

Read Answer Asked by Giannis on May 13, 2022

• Merck & Company Inc. (MRK $110.53)
  • $110.53 P/E (TTM): 14.67X Cap: $274.33B
  • View MRK Profile
  • View Questions on MRK
• Pfizer Inc. (PFE $25.48)
  • $25.48 P/E (TTM): 14.7X Cap: $144.87B
  • View PFE Profile
  • View Questions on PFE

Q: Hi,
If choosing between Pfizer and Merck today for a long term hold (5-10 years), which would you choose and why please. Thanks very much.
Michael

Upvote 0

Read Answer Asked by Michael on May 12, 2022

• WELL Health Technologies Corp. (WELL $4.23)
  • $4.23 Cap: $1.07B
  • View WELL Profile
  • View Questions on WELL
  • View Reports on WELL

Q: To me WELL is hitting on all cylinders but it is unloved within the market. This from it's latest results:

WELL reported record quarterly revenues of $126.5 million in Q1-2022 representing a 395% year-over-year (YoY) increase compared to Q1-2021, catapulting the Company to over $500 million annualized revenue run-rate. Revenues reflected accelerating organic growth to 15% on a YoY basis

I have held it for a while now and am under water. Granted we are in a down market but do you think this stock will get more attention once the market hits bottom [when ever that is] and starts to move up?

Thanks

Upvote 0

Read Answer Asked by Ronald on May 12, 2022

• Savaria Corporation (SIS $23.86)
  • $23.86 P/E (TTM): 27.24X Cap: $1.70B
  • View SIS Profile
  • View Questions on SIS
  • View Reports on SIS

Q: will SIS be able to keep paying dividends? Thanks.

Upvote 0

Read Answer Asked by Francis on May 12, 2022

• Savaria Corporation (SIS $23.86)
  • $23.86 P/E (TTM): 27.24X Cap: $1.70B
  • View SIS Profile
  • View Questions on SIS
  • View Reports on SIS

Q: Please comment on Savaria Corps earnings. Thanks.

Upvote 0

Read Answer Asked by Craig on May 12, 2022